To include your compound in the COVID-19 Resource Center, submit it here.

July 8 Quick Takes: CapitalBio raises $113M, plans Shanghai IPO; plus Aidea, CF PharmTech, Denovo, Nucleai and Vaxdyn

CapitalBio Technology raises over $113M in pre-IPO round
CapitalBio Corp. subsidiary CapitalBio Technology Co Ltd. raised over RMB800 million ($113 million) in a pre-IPO financing round last week led by Guangdong Boyi Design Institute Co. Ltd. with participation

Read the full 376 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers